Among the 26 patients with RCC, 20 (76.9%) had Xp11.2 translocations/TFE3 gene fusion, 3 had papillary carcinoma, 2 had clear cell carcinoma, and 1 had chromophobe cell carcinoma. This evidence concerns the gene TFE3 and renal cell adenocarcinoma.